A specialized gene editing system designed by scientists at the Lewis Katz School of Medicine at Temple University is paving the way to an eventual cure for patients infected with HIV, the virus that causes AIDS. In a study published online this month in the Nature journal, Scientific Reports, the researchers show that they can both effectively and safely eliminate the virus from the DNA of human cells grown in culture.
According to senior investigator on the new study, Kamel Khalili, PhD, Laura H. Carnell Professor and Chair of the Department of Neuroscience, Director of the Center for Neurovirology, and Director of the Comprehensive NeuroAIDS Center at the Lewis Katz School of Medicine at Temple University (LKSOM), “Antiretroviral drugs are very good at controlling HIV infection. But patients on antiretroviral therapy who stop taking the drugs suffer a rapid rebound in HIV replication.” The presence of numerous copies of HIV weakens the immune system and eventually causes acquired immune deficiency syndrome, or AIDS.
Curing HIV/AIDS – which has claimed the lives of more than 25 million people since it was first discovered in the 1980s – is the ultimate goal in HIV research. But eliminating the virus after it has become integrated into CD4+ T-cells, the cells primarily infected with HIV, has proven difficult. Recent attempts have focused on intentionally reactivating HIV, aiming to stimulate a robust immune response capable of eradicating the virus from infected cells. However, to date, none of these “shock and kill” approaches has been successful.
Dr. Khalili and colleagues decided to try a different approach, specifically targeting HIV-1 proviral DNA (the integrated viral genome) using uniquely tailored gene editing technology. Their system includes a guide RNA that specifically locates HIV-1 DNA in the T-cell genome, and a nuclease enzyme, which cuts the strands of T-cell DNA. Once the nuclease has edited out the HIV-1 DNA sequence, the loose ends of the genome are reunited by the cell’s own DNA repair machinery.
In previous work, Dr. Khalili’s team had demonstrated the ability of their technology to snip out HIV-1 DNA from human cell lines. In their latest study, however, they concentrated on latently and productively infected CD4+ T cells to show not only that the technology eliminates the virus from cells but also that its persistent presence in HIV-1-eradicated cells actually protects them against reinfection. More importantly, they carried their work over to ex vivo experiments, in which T-cells from patients infected with HIV were grown in cell culture, showing that treatment with the gene editing system can suppress viral replication and dramatically reduce viral load in patient cells.
In another major component of the study, Dr. Khalili’s team addressed questions about off-target effects and toxicity. Using an approach known as ultra-deep whole-genome sequencing, which is considered the gold standard for genomic assessment, the researchers analyzed the genomes of HIV-1-eradicated cells for mutations in genes outside the region targeted by the guide RNA. Their analyses ruled out off-target effects on genes, including potential collateral effects on cellular gene expression. Studies of cell viability and proliferation showed that HIV-1-eradicated cells were growing and functioning normally.
“The findings are important on multiple levels,” Dr. Khalili said. “They demonstrate the effectiveness of our gene editing system in eliminating HIV from the DNA of CD4 T-cells and, by introducing mutations into the viral genome, permanently inactivating its replication. Further, they show that the system can protect cells from reinfection and that the technology is safe for the cells, with no toxic effects.”
“These experiments had not been performed previously to this extent,” he added. “But the questions they address are critical, and the results allow us to move ahead with this technology.”
The Latest on: HIV/AIDS
[google_news title=”” keyword=”HIV/AIDS” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: HIV/AIDS
- Expect injectables for HIV treatment soon — Dr Ilori, NACA DGon May 9, 2024 at 12:32 am
Director General of the National Agency for Control of AIDS, Dr Temitope Ilori, speaks in this interview with Sade Oguntola about Nigeria’s steps to revitalise the HIV response and to end HIV as a ...
- Global HIV Diagnostics Market Poised for Remarkable Growth targeting USD 6.4 Billion by 2032 at a CAGR of 7.9%: Future Market Insights Reporton May 8, 2024 at 8:28 pm
The global HIV diagnostics market is set to experience a significant surge, as projected by the latest report from Future Market Insights. With anticipated growth from USD 3.0 billion in 2022 to an ...
- Idaho man who tried to spread HIV goes to prisonon May 8, 2024 at 6:00 pm
A Boise man who was initially arrested on a slew of felony sex charges has been sentenced to multiple years in prison for sexually assaulting a teenager and attempting to “purposefully” transfer HIV.
- Mayor's office: 'Too early to tell' if city will backfill expected federal HIV cutson May 8, 2024 at 3:06 pm
A spokesperson for Mayor London Breed said May 8 that it’s "too early to tell" whether her proposed budget will backfill an expected $500,000-$800,000 shortfall in HIV funding from the federal ...
- Fundraiser to benefit Nashville AIDS service organizationon May 8, 2024 at 9:13 am
N ASHVILLE, Tenn. (WSMV) – An annual fundraiser to help raise money for Nashville CARES, the leading HIV/AIDS organization “amplifying sexual wellness amongst Middle Tennessee residents,” begins ...
- NACA Empowers Youths On Social Media Advocacy Against HIV/AIDSon May 8, 2024 at 2:58 am
National Agency for the Control of AIDS (NACA) has empowered National Youth Service Corps (NYSC) members and selected interns with essential skills in ...
- Fact Check: HIV cannot have been transmitted by water in Texas swimming poolon May 7, 2024 at 9:53 am
Decades of research show it is not possible for HIV to be transmitted through the water in a swimming ... “HOA Pool Infected with AIDS. 4th person positive. 4th person tested positive this week. Make ...
- HIV and AIDS Newson May 6, 2024 at 4:59 pm
The children, who acquired HIV before birth, were ... Breakthrough in Developing the PD-1-Enhanced DNA Vaccine for Over 6-Year cART-Free AIDS Prevention and Virologic Control Feb. 20, 2024 ...
- HIV doesn’t spread through pools but some online users wrongly claim people are getting infectedon May 3, 2024 at 11:11 am
As Stanford Medicine notes, HIV is spread most commonly by sexual contact with an infected partner. It can also spread through contact with infected blood and by sharing needles and syringes. The ...
- R&B artist Raheem DeVaughn sings soulful tune for Gilead to combat HIVon May 2, 2024 at 1:06 pm
Grammy nominee and recording artist Raheem DeVaughn is working with Gilead Sciences to increase awareness of HIV preventive care among Black women.
via Bing News